Cases:Gene-corrected autologous hematopoietic stem cell therapy

2 trials

Sponsors

Dongguan Taixin Hospital

Conditions

Severe beta-thalassemiahemophilia B

Early Phase 1

Canceled by investigator Clinical study for the efficacy and safety of gene-corrected autologous hematopoietic stem cell transplantation in the treatment of severe ß-thalassemia

Active, not recruitingChiCTR2000031648

Dongguan Taixin HospitalSevere beta-thalassemia

Start: 2020-04-01Updated: 2020-08-03

Canceled by the investigator Clinical study for the effectiveness and safety of gene-corrected autologous hematopoietic stem cell transplantation in the treatment of hemophilia B

Active, not recruitingChiCTR2000031647

Dongguan Taixin Hospitalhemophilia B

Start: 2020-04-01Updated: 2020-08-03